Karl Bélanger
- Genetics top 0.01%
- Molecular Biology top 1%
- Pulmonary and Respiratory Medicine top 0.2%
- Cancer Research top 0.2%
- Oncology top 0.5%
- Co-authors
- Elizabeth A. EisenhauerWarren MasonThierry GorliaMichael WellerMartin J. van den BentDenis LacombeAnouk AllgeierRoger Stupp
- Topics
- Cancer Immunotherapy and Biomarkers (11 papers)Glioma Diagnosis and Treatment (10 papers)Brain Metastases and Treatment (8 papers)
- Partner nations
- CanadaUnited StatesNew Zealand
In The Last Decade
Karl Bélanger
38 papers receiving 17.4k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Genetics 11.3k
- Molecular Biology 6.0k
- Pulmonary and Respiratory Medicine 4.1k
- Cancer Research 3.8k
- Oncology 3.4k
Countries citing papers authored by Karl Bélanger
This map shows the geographic impact of Karl Bélanger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Bélanger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Bélanger more than expected).
Fields of papers citing papers by Karl Bélanger
This network shows the impact of papers produced by Karl Bélanger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Bélanger. The network helps show where Karl Bélanger may publish in the future.
Co-authorship network of co-authors of Karl Bélanger
This figure shows the co-authorship network connecting the top 25 collaborators of Karl Bélanger. A scholar is included among the top collaborators of Karl Bélanger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Bélanger. Karl Bélanger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 6 | |
| 4 | 6 | |
| 5 | 38 | |
| 6 | 1 | |
| 7 | 95 | |
| 8 | 33 | |
| 9 | 264 | |
| 10 | 155 | |
| 11 | 412 | |
| 12 | 83 | |
| 13 | Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastomabreakdown → | 15995 |
| 14 | 89 | |
| 15 | 3 | |
| 16 | 35 | |
| 17 | 12 | |
| 18 | 6 | |
| 19 | 24 | |
| 20 | Incorporation of iododeoxyuridine into DNA of granulocytes in patients. | 22 |
About Karl Bélanger
Karl Bélanger is a scholar working on Genetics, Oncology and Immunology, having authored 39 papers that have together received 17.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Glioma Diagnosis and Treatment (10 papers) and Brain Metastases and Treatment (8 papers). The work is most often cited by research in Genetics (11.3k citations), Cancer Research (3.8k citations) and Pulmonary and Respiratory Medicine (4.1k citations). Karl Bélanger has collaborated with scholars based in Canada, United States and New Zealand. Frequent co-authors include Elizabeth A. Eisenhauer, Warren Mason, Thierry Gorlia, Michael Weller, Martin J. van den Bent, Denis Lacombe, Anouk Allgeier, Roger Stupp, R.O. Mirimanoff and Alba A. Brandes. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.